跳至主要内容
临床试验/ISRCTN93069723
ISRCTN93069723已完成不适用

Double intra-ocular lens implant for visual rehabilitation of patients with dry age-related macular degeneration

See Again Europe Ltd (UK)0 个研究点目标入组 7 人开始时间: 2012年11月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
7

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. The ophthalmic surgeon will select suitable patients
  • 2. Patients with significant stable macular degeneration (dry), ideally with less than two disc diameters of ARMD
  • 3. Patients must have significant lens opacities in the affected eye and a visual acuity of <6/36
  • 4. Patients must have an endothelial cell count greater than 1,600 per square mm in the affected eye
  • 5. Patients must demonstrate a positive screening test result when using the the See Again assessment lens set i.e. exhibit at least a two line improvement when reading the ETDRS Chart

排除标准

  • 1. Patients with active ARMD
  • 2. Patients with active ocular inflammation
  • 3. Patients with previous cataract surgery
  • 4. Patients with lack of mental capability to give informed consent
  • 5. Patients with an inability to understand spoken and written English
  • 6. Patients who are involved or have been involved in a research study

研究者

发起方
See Again Europe Ltd (UK)

相似试验